ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Pain Management Drugs Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-1O15398
Home | Market Reports | Health| Health Conditions| Pain Management
Global Chronic Pain Management Drugs Market Insights Forecast to 2029
BUY CHAPTERS

Global Chronic Pain Management Drugs Market Research Report 2025

Code: QYRE-Auto-1O15398
Report
January 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Depomed
Endo International Plc.
Purdue Pharma L.P
Novartis
Astrazeneca plc
Johnson and Johnson Services Inc.
Merck
Abbott Laboratories
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd

Chronic Pain Management Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chronic Pain Management Drugs Market

Chronic Pain Management Drugs Market

The global market for Chronic Pain Management Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Pain Management Drugs.
The Chronic Pain Management Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Pain Management Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chronic Pain Management Drugs Market Report

Report Metric Details
Report Name Chronic Pain Management Drugs Market
CAGR 5%
Segment by Type
  • Opioids
  • Non-narcotic Analgesic
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Depomed Inc., Endo International plc., Purdue Pharma L.P., Novartis AG, AstraZeneca plc., Johnson and Johnson Services Inc., Merck & Co., Abbott Laboratories, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chronic Pain Management Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Pain Management Drugs Market report?

Ans: The main players in the Chronic Pain Management Drugs Market are Pfizer Inc., Depomed Inc., Endo International plc., Purdue Pharma L.P., Novartis AG, AstraZeneca plc., Johnson and Johnson Services Inc., Merck & Co., Abbott Laboratories, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Chronic Pain Management Drugs Market report?

Ans: The Applications covered in the Chronic Pain Management Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Chronic Pain Management Drugs Market report?

Ans: The Types covered in the Chronic Pain Management Drugs Market report are Opioids, Non-narcotic Analgesic, Others

Recommended Reports

Pain Treatment Drugs

Chronic Disease Drugs

Pain Management Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Pain Management Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Opioids
1.2.3 Non-narcotic Analgesic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chronic Pain Management Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Pain Management Drugs Market Perspective (2020-2031)
2.2 Global Chronic Pain Management Drugs Growth Trends by Region
2.2.1 Global Chronic Pain Management Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Pain Management Drugs Historic Market Size by Region (2020-2025)
2.2.3 Chronic Pain Management Drugs Forecasted Market Size by Region (2026-2031)
2.3 Chronic Pain Management Drugs Market Dynamics
2.3.1 Chronic Pain Management Drugs Industry Trends
2.3.2 Chronic Pain Management Drugs Market Drivers
2.3.3 Chronic Pain Management Drugs Market Challenges
2.3.4 Chronic Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Pain Management Drugs Players by Revenue
3.1.1 Global Top Chronic Pain Management Drugs Players by Revenue (2020-2025)
3.1.2 Global Chronic Pain Management Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Pain Management Drugs Revenue
3.4 Global Chronic Pain Management Drugs Market Concentration Ratio
3.4.1 Global Chronic Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Pain Management Drugs Revenue in 2024
3.5 Global Key Players of Chronic Pain Management Drugs Head office and Area Served
3.6 Global Key Players of Chronic Pain Management Drugs, Product and Application
3.7 Global Key Players of Chronic Pain Management Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Pain Management Drugs Breakdown Data by Type
4.1 Global Chronic Pain Management Drugs Historic Market Size by Type (2020-2025)
4.2 Global Chronic Pain Management Drugs Forecasted Market Size by Type (2026-2031)
5 Chronic Pain Management Drugs Breakdown Data by Application
5.1 Global Chronic Pain Management Drugs Historic Market Size by Application (2020-2025)
5.2 Global Chronic Pain Management Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Pain Management Drugs Market Size (2020-2031)
6.2 North America Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Pain Management Drugs Market Size by Country (2020-2025)
6.4 North America Chronic Pain Management Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Pain Management Drugs Market Size (2020-2031)
7.2 Europe Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Pain Management Drugs Market Size by Country (2020-2025)
7.4 Europe Chronic Pain Management Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Management Drugs Market Size (2020-2031)
8.2 Asia-Pacific Chronic Pain Management Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Pain Management Drugs Market Size (2020-2031)
9.2 Latin America Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Pain Management Drugs Market Size by Country (2020-2025)
9.4 Latin America Chronic Pain Management Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Management Drugs Market Size (2020-2031)
10.2 Middle East & Africa Chronic Pain Management Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Chronic Pain Management Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Depomed Inc.
11.2.1 Depomed Inc. Company Details
11.2.2 Depomed Inc. Business Overview
11.2.3 Depomed Inc. Chronic Pain Management Drugs Introduction
11.2.4 Depomed Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.2.5 Depomed Inc. Recent Development
11.3 Endo International plc.
11.3.1 Endo International plc. Company Details
11.3.2 Endo International plc. Business Overview
11.3.3 Endo International plc. Chronic Pain Management Drugs Introduction
11.3.4 Endo International plc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.3.5 Endo International plc. Recent Development
11.4 Purdue Pharma L.P.
11.4.1 Purdue Pharma L.P. Company Details
11.4.2 Purdue Pharma L.P. Business Overview
11.4.3 Purdue Pharma L.P. Chronic Pain Management Drugs Introduction
11.4.4 Purdue Pharma L.P. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.4.5 Purdue Pharma L.P. Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Chronic Pain Management Drugs Introduction
11.5.4 Novartis AG Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.5.5 Novartis AG Recent Development
11.6 AstraZeneca plc.
11.6.1 AstraZeneca plc. Company Details
11.6.2 AstraZeneca plc. Business Overview
11.6.3 AstraZeneca plc. Chronic Pain Management Drugs Introduction
11.6.4 AstraZeneca plc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.6.5 AstraZeneca plc. Recent Development
11.7 Johnson and Johnson Services Inc.
11.7.1 Johnson and Johnson Services Inc. Company Details
11.7.2 Johnson and Johnson Services Inc. Business Overview
11.7.3 Johnson and Johnson Services Inc. Chronic Pain Management Drugs Introduction
11.7.4 Johnson and Johnson Services Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.7.5 Johnson and Johnson Services Inc. Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Details
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Chronic Pain Management Drugs Introduction
11.8.4 Merck & Co. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.8.5 Merck & Co. Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Chronic Pain Management Drugs Introduction
11.9.4 Abbott Laboratories Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.9.5 Abbott Laboratories Recent Development
11.10 GlaxoSmithKline plc.
11.10.1 GlaxoSmithKline plc. Company Details
11.10.2 GlaxoSmithKline plc. Business Overview
11.10.3 GlaxoSmithKline plc. Chronic Pain Management Drugs Introduction
11.10.4 GlaxoSmithKline plc. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.10.5 GlaxoSmithKline plc. Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Details
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Chronic Pain Management Drugs Business (2020-2025)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Depomed
Endo International Plc.
Purdue Pharma L.P
Novartis
Astrazeneca plc
Johnson and Johnson Services Inc.
Merck
Abbott Laboratories
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd
List of Tables
 Table 1. Global Chronic Pain Management Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Opioids
 Table 3. Key Players of Non-narcotic Analgesic
 Table 4. Key Players of Others
 Table 5. Global Chronic Pain Management Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Chronic Pain Management Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Chronic Pain Management Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Chronic Pain Management Drugs Market Share by Region (2020-2025)
 Table 9. Global Chronic Pain Management Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Chronic Pain Management Drugs Market Share by Region (2026-2031)
 Table 11. Chronic Pain Management Drugs Market Trends
 Table 12. Chronic Pain Management Drugs Market Drivers
 Table 13. Chronic Pain Management Drugs Market Challenges
 Table 14. Chronic Pain Management Drugs Market Restraints
 Table 15. Global Chronic Pain Management Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Chronic Pain Management Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Chronic Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Management Drugs as of 2024)
 Table 18. Ranking of Global Top Chronic Pain Management Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Chronic Pain Management Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Chronic Pain Management Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Chronic Pain Management Drugs, Product and Application
 Table 22. Global Key Players of Chronic Pain Management Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Chronic Pain Management Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Chronic Pain Management Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Chronic Pain Management Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Chronic Pain Management Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Chronic Pain Management Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Chronic Pain Management Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Chronic Pain Management Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Chronic Pain Management Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Chronic Pain Management Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pfizer Inc. Company Details
 Table 48. Pfizer Inc. Business Overview
 Table 49. Pfizer Inc. Chronic Pain Management Drugs Product
 Table 50. Pfizer Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 51. Pfizer Inc. Recent Development
 Table 52. Depomed Inc. Company Details
 Table 53. Depomed Inc. Business Overview
 Table 54. Depomed Inc. Chronic Pain Management Drugs Product
 Table 55. Depomed Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 56. Depomed Inc. Recent Development
 Table 57. Endo International plc. Company Details
 Table 58. Endo International plc. Business Overview
 Table 59. Endo International plc. Chronic Pain Management Drugs Product
 Table 60. Endo International plc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 61. Endo International plc. Recent Development
 Table 62. Purdue Pharma L.P. Company Details
 Table 63. Purdue Pharma L.P. Business Overview
 Table 64. Purdue Pharma L.P. Chronic Pain Management Drugs Product
 Table 65. Purdue Pharma L.P. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 66. Purdue Pharma L.P. Recent Development
 Table 67. Novartis AG Company Details
 Table 68. Novartis AG Business Overview
 Table 69. Novartis AG Chronic Pain Management Drugs Product
 Table 70. Novartis AG Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 71. Novartis AG Recent Development
 Table 72. AstraZeneca plc. Company Details
 Table 73. AstraZeneca plc. Business Overview
 Table 74. AstraZeneca plc. Chronic Pain Management Drugs Product
 Table 75. AstraZeneca plc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 76. AstraZeneca plc. Recent Development
 Table 77. Johnson and Johnson Services Inc. Company Details
 Table 78. Johnson and Johnson Services Inc. Business Overview
 Table 79. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Product
 Table 80. Johnson and Johnson Services Inc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 81. Johnson and Johnson Services Inc. Recent Development
 Table 82. Merck & Co. Company Details
 Table 83. Merck & Co. Business Overview
 Table 84. Merck & Co. Chronic Pain Management Drugs Product
 Table 85. Merck & Co. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 86. Merck & Co. Recent Development
 Table 87. Abbott Laboratories Company Details
 Table 88. Abbott Laboratories Business Overview
 Table 89. Abbott Laboratories Chronic Pain Management Drugs Product
 Table 90. Abbott Laboratories Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 91. Abbott Laboratories Recent Development
 Table 92. GlaxoSmithKline plc. Company Details
 Table 93. GlaxoSmithKline plc. Business Overview
 Table 94. GlaxoSmithKline plc. Chronic Pain Management Drugs Product
 Table 95. GlaxoSmithKline plc. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 96. GlaxoSmithKline plc. Recent Development
 Table 97. Teva Pharmaceutical Industries Ltd. Company Details
 Table 98. Teva Pharmaceutical Industries Ltd. Business Overview
 Table 99. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Product
 Table 100. Teva Pharmaceutical Industries Ltd. Revenue in Chronic Pain Management Drugs Business (2020-2025) & (US$ Million)
 Table 101. Teva Pharmaceutical Industries Ltd. Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. Chronic Pain Management Drugs Picture
 Figure 2. Global Chronic Pain Management Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chronic Pain Management Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Opioids Features
 Figure 5. Non-narcotic Analgesic Features
 Figure 6. Others Features
 Figure 7. Global Chronic Pain Management Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Chronic Pain Management Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Others Case Studies
 Figure 12. Chronic Pain Management Drugs Report Years Considered
 Figure 13. Global Chronic Pain Management Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Chronic Pain Management Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Chronic Pain Management Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Chronic Pain Management Drugs Market Share by Players in 2024
 Figure 17. Global Top Chronic Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Management Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Chronic Pain Management Drugs Revenue in 2024
 Figure 19. North America Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Chronic Pain Management Drugs Market Share by Country (2020-2031)
 Figure 21. United States Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Chronic Pain Management Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Chronic Pain Management Drugs Market Share by Region (2020-2031)
 Figure 33. China Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Chronic Pain Management Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Chronic Pain Management Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Chronic Pain Management Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 49. Depomed Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 50. Endo International plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 51. Purdue Pharma L.P. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 52. Novartis AG Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 53. AstraZeneca plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 54. Johnson and Johnson Services Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 55. Merck & Co. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 56. Abbott Laboratories Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 57. GlaxoSmithKline plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 58. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Chronic Pain Management Drugs Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Low Back Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Pelvic Pain Treatment Market Research Report 2025
Pain Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Pain Medicines Market Research Report 2024
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Back and Spine Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Opioid Analgesics Market Research Report 2025
Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non opioid Pain Med Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Pain Relievers for External Use Market Research Report 2025
Neck Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Reliever Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Complex Regional Pain Syndrome Treatment Market Research Report 2025
Global Post operative Pain Therapeutics Market Research Report 2025
Non opioid Topical Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anaesthetic Drugs and Pain Drugs Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions